Press "Enter" to skip to content

New patent expiration for Abbvie Inc drug ORILISSA

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug ORILISSA

Annual Drug Patent Expirations for ORILISSA
Annual Drug Patent Expirations for ORILISSA

Orilissa is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.

ORILISSA drug price trends.

This drug has forty-seven patent family members in twenty-four countries.

The generic ingredient in ORILISSA is elagolix sodium. One supplier is listed for this compound. Additional details are available on the elagolix sodium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug ORILISSA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions